MedTrace Logo

Probiotics in Intestinal Bacterial Overgrowth

NCT02204891 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2017-03-20

No results posted yet for this study

Summary

The aim of the present study is to demonstrate the effect of a mixture of four species of probiotics (Saccharomyces boulardii, Bifidobacterium lactis BB-12, Lactobacillus acidophilus LA-5 and Lactobacillus plantarum) in patients with symptomatic irritable bowel syndrome (IBS) who have culture verified syndrome of intestinal bacterial overgrowth (SIBO) and those who do not have. This will provide direct evidence for the role of probiotics in treating part of the pathogenesis of IBS.

Conditions

  • Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

Probiotics

One capsule twice daily for 30 days

DIETARY_SUPPLEMENT

Probiotics in SIBO

Mixture of the four probiotics in one capsule. One capsule twice daily for 30 days

Sponsors & Collaborators

  • University of Athens

    lead OTHER

Principal Investigators

  • Konstantinos Triantafyllou, MD, PhD · University of Athens, Medical School

  • Evangelos Giamarellos-Bourboulis, MD, PhD · University of Athens, Medical School

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-06-30
Completion
2016-09-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02204891 on ClinicalTrials.gov